Steven K. Libutti, M.D.
Surgery Branch
Head, Tumor Angiogenesis Section
Senior Investigator
National Cancer Institute
9000 Rockville Pike
Building 10, Room 4W-5940
Bethesda, MD 20892
Phone: 301-496-5049
Fax: 301-402-1788
libuttis@mail.nih.gov
Dr. Libutti received his A.B. from Harvard University and his M.D. from the College of Physicians and Surgeons of Columbia University. He completed his surgical residency at the Presbyterian Hospital in New York and a fellowship in surgical oncology and endocrine surgery in the Surgery Branch of the National Cancer Institute (NCI). After completing his training, he joined the staff of the Surgery Branch and is currently a tenured senior investigator and the section chief of the Tumor Angiogenesis Section. He is a fellow of the American College of Surgeons, the Society of Surgical Oncology, and the Society of University Surgeons. He is a member of the American Association for Cancer Research, the American Society of Clinical Oncology and the American Association of Endocrine Surgeons. Dr. Libutti is studying tumor neovascular formation and the interaction between tumor cells, endothelial cells and the components of the tumor microenvironment. His clinical expertise is in the management of malignancies of the liver, pancreas, and GI tract, and in applying laparoscopic surgery to managing patients with malignancies. In addition, Dr. Libutti is an internationally recognized expert in endocrine surgery and provides surgical consultation and treatment for patients with disorders of the thyroid, parathyroid, adrenal glands, and for endocrine tumors arising in the pancreas. Dr. Libutti has received numerous awards related to his work, including the NCI Technology Transfer Award, the NCI Director's Gold Star Award, the NCI Director's Innovation Award and the National Institutes of Health Director's Award.
There are no trials listed for this investigator at this time. Please check back for updates. You may also visit the Search for Clinical Trials at NIH page to find trials conducted by other investigators.
Back to Top
